Status: Recruiting
Pilot Study to Evaluate Targeted Physical Activity Among Pancreatic Cancer Patients Receiving Neoadjuvant Chemotherapy
Patients with pancreatic cancer receiving neoadjuvant chemotherapy often experience functional decline, treatment interruptions, and clinical deterioration, and these risks may be amplified when frailty is present.
Participants needed: 25
Trial details
Age: 18+Biological sex: AllType: InterventionalSponsor: University of Illinois at ChicagoUpdated: Jun 24, 2026Locations: 1
Eligibility criteria
Age ≥18 years [+6]
Adults unable to consent. [+4]